Swab and Viral Transport Market is expected to reach a size of USD 15.60 billion, growing at a 5.8% CAGR By 2033 | FMI

Swab and Viral Transport Market

The fight against infectious diseases is getting a boost from a crucial tool. The Swab and Viral Transport Market. According to a recent analysis by Future Market Insights (FMI), the global market for these tools is expected to reach a staggering USD 15.6 billion by 2033. This translates to a significant projected growth at a Compound Annual Growth Rate (CAGR) of 5.8%. The market has already reached a value of over USD 8.86 billion in 2023, highlighting the ongoing need for efficient sample collection and transportation.

Due to the COVID-19 outbreak, swabs and viral delivery mediums are in greater demand. Research centers and labs are working harder to develop COVID-19 vaccines, which has enhanced enterprises’ capacity to make goods suitable for viral collection, maintenance, and culture.

Innovative kits with vials, double-ended flocked swabs, pharmaceuticals, and other goods that prevent bacterial or fungal contamination are produced by businesses in the swab and viral transport medium industry. To halt the development of bacterial and fungal flora, they are focusing on developing a better solution formulation. New solutions for viral transport mediums are driving market growth.

Request Sample Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-11195

The increase of novel viruses that can infect people and cause a variety of ailments is another factor driving the market’s expansion. Some respiratory viruses are emerging in unanticipated ways as pandemic restrictions loosen, according to a 2021 Nature paper. Respiratory syncytial virus (RSV) infections, which cause 5% of all pediatric fatalities worldwide, started to increase in April 2021. The prevalence of more infectious diseases is anticipated to fuel market expansion due to the growing demand for specimen collection kits and diagnosis.

As the flu season begins, manufacturers are developing viral transmission mediums for diagnostic purposes. Healthcare in Western countries is very concerned about morbidity and mortality caused by influenza. The ability of manufacturers to do research and development is growing as they give swabs and viral transmission mediums. The benefits of Internet pharmacy over hospitals and traditional pharmacies are also beginning to be understood by manufacturers. They are collaborating with reputable e-commerce businesses to expand their sources of income.

Owing to its highly developed medical infrastructure and high frequency of infectious illnesses, North America is predicted to dominate the global market during the forecast period. During the pandemic, North America saw a spike in laboratory testing, which fueled the market expansion. The market is also growing significantly due to the existence of biopharma businesses, a large number of labs, and research studies on viral infection.

Swab and Viral Transport Market Key Takeaways

• The market in the United Kingdom is anticipated to rise, exhibiting a CAGR of 5.9% through 2033.
• The United States is expected to develop at a 6.1% CAGR during the forecast period.
• With a CAGR of 4.0% over the forecast period, Canada is predicted to develop promptly in the market.
• In China, the market is expected to proliferate, registering a CAGR of 7.7% over the forecast period.
• Germany is estimated to grow decently registering a CAGR of 6.7% until 2033.

Swab and Viral Transport Market Competitive Landscape

Top players operating in the swab and viral transport medium market are McKesson Corporation, Cardinal Health Inc., Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Quidel Corporation, COPAN Diagnostics Inc., VIRCELL S.L., Deltalab, Titan Biotech Ltd., Medical Wire & Equipment, and others.

These market players are always inventing and creating new products to suit the various requirements of diagnostic laboratories and research institutions. They are enhancing the design and components used in swabs to enhance their collection efficacy. They are also developing transport mediums that can hold viral specimens for extended periods without compromising their vitality. Additionally, to improve the stability and accuracy of diagnostic samples, they are also combining advanced technologies.

Request Customization
https://www.futuremarketinsights.com/customization-available/rep-gb-11195

Swab and Viral Transport Market Recent Developments

• In June 2022, the start of long-distance drone deliveries in North Carolina was announced by Zipline and Cardinal Health.
• In May 2020, in several pharmacies across the United States, Health Mart® pharmacies announced that they would provide free COVID-19 test collection. Health Mart is dedicated to creating cutting-edge public and private collaborations as a member of the McKesson Corporation to assist address the COVID-19 epidemic.

Other Key Players Operating in the Swab and Viral Transport Market

• Thermo Fisher Scientific Inc.,
• Quidel Corporation,
• COPAN Diagnostics Inc.,
• VIRCELL S.L., Deltalab,
• Titan Biotech Ltd.,
• Medical Wire & Equipment

Swab and Viral Transport Medium Market by Category

By Product:

• Viral Transport Medium
  • Tissue Culture Medium
  • Glycerol Transport Medium
• Virus Swabs
  • Nasopharyngeal Swabs
  • Deep Nasal Swabs
  • Combined Nasal & Throat Swabs
  • Culture Swabs
  • Vaginal Swabs

By Application:

• Influenza
• Respiratory syncytial virus
• Mumps Virus
• Adenovirus
• Rhinovirus
• Herpes Simplex Virus
• Varicella-Zoster Virus
• Other Indication

By End User:

• Hospitals & ASCs
• Specialty Clinics
• Diagnostic Laboratories
• Others

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube